Establishes immunity from liability for certain designers, manufacturers, sellers, and lessors of products
SB 552 would add a new section to Missouri law governing civil actions involving product-related personal injury, death, or property damage. The bill requires a plaintiff to prove that the defendant designed, manufactured, sold, or leased the specific product that allegedly caused the harm, rather than a similar or equivalent product. It also bars liability for designers, manufacturers, sellers, or lessors whose products were not actually identified as being used, ingested, or encountered by the injured party.
The bill further provides that a person or business whose design was copied or used without express authorization by a manufacturer would not be liable for injuries caused by the manufacturer’s product, even if that use of the design was foreseeable. At the same time, the bill states that it does not change other laws that may apply to successor entities, distributors, component manufacturers, manufacturers using component parts, or contract/licensing issues.
If enacted, SB 552 would narrow product-liability claims by making identification of the exact product and responsible defendant a statutory requirement in civil actions for personal injury, death, or property damage. This would likely make it more difficult for plaintiffs to pursue claims based on similar products, copied designs, or broader theories of liability against parties not directly tied to the specific product involved. The bill expressly preserves existing law on successor liability, distributors, component manufacturers, assembled products, and contractual or licensing arrangements, so those areas would continue to be governed by current statutes and common law.
Based on the bill’s caption and text, the measure appears to reflect a pro-business, liability-limiting approach intended to protect product designers and sellers from expansive lawsuits. Because there are no committee transcripts or recorded votes provided, there is no documented debate or formal legislative sentiment in the supplied materials. The available context suggests the bill was introduced as a targeted tort-reform measure rather than a broadly contested policy change.
The main point of contention is likely whether the bill unfairly restricts injured plaintiffs’ ability to recover by requiring proof of the exact product and by shielding designers whose work is copied without authorization. Supporters would likely view the bill as preventing liability for parties not directly responsible for the harmful product, while opponents would likely argue it could close off legitimate claims where product identification is difficult or where design involvement contributed to the injury. The bill’s carve-outs for successor entities, distributors, component manufacturers, and licensing agreements indicate an effort to avoid disrupting existing liability rules in related areas.